#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15870	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1991	788.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1417	1417	C	890	C,T	837,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28778	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3432	834.3	0	.	n	.	0	T695C	SNP	695	695	T	994	994	C	927	C,A	870,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28778	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3432	834.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1636	1636	A	944	A,G	895,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28778	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3432	834.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2270	2270	C	922	C,G,T	846,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28778	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3432	834.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2344	2344	A	888	A	831	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28778	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3432	834.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2896	2896	C	904	C	845	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	1888	folP	855	855	100.0	folP.l15.c4.ctg.1	1640	114.8	1	SNP	p	R229S	0	.	.	685	687	CGC	1143	1145	CGC	175;173;173	C;G;C	161;160;158	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5004	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3259	152.6	1	SNP	p	S91F	0	.	.	271	273	TCC	530	532	TCC	174;173;173	T;C;C	165;163;164	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5004	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3259	152.6	1	SNP	p	D95G	0	.	.	283	285	GAC	542	544	GAC	166;169;172	G;A;C	158;162;162	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5004	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3259	152.6	1	SNP	p	D95N	0	.	.	283	285	GAC	542	544	GAC	166;169;172	G;A;C	158;162;162	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1580	mtrR	633	633	99.68	mtrR.l15.c30.ctg.1	1428	110.2	0	.	p	.	0	S32W	NONSYN	94	96	TCG	533	535	TGG	199;201;204	T;G,C,T;G	182;181,1,1;186	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1580	mtrR	633	633	99.68	mtrR.l15.c30.ctg.1	1428	110.2	0	.	p	.	0	D79N	NONSYN	235	237	GAT	674	676	AAT	185;184;185	A,G;A;T	166,1;166;166	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1580	mtrR	633	633	99.68	mtrR.l15.c30.ctg.1	1428	110.2	1	SNP	p	G45D	0	.	.	133	135	GGC	572	574	GGC	188;189;187	G;G,A;C	176;175,1;175	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	828	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	902	91.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5068	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3035	166.3	1	SNP	p	D86N	0	.	.	256	258	GAC	597	599	GAC	225;226;225	G;A;C	207;206;210	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5068	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3035	166.3	1	SNP	p	S88P	0	.	.	262	264	TCC	603	605	TCC	226;229;230	T;C;C	209;212;215	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4236	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2501	167.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1470	1472	GGC	225;223;222	G;G;C	210;207;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3912	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2243	172.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1186	1188	GCA	207;208;212	G,A;C;A	185,1;189;196	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3912	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2243	172.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1189	1191	ATC	212;212;214	A;T;C	194;192;197	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3912	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2243	172.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1201	1203	GTG	211;209;211	G;T;G	194;194;193	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3912	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2243	172.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1201	1203	GTG	211;209;211	G;T;G	194;194;193	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3912	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2243	172.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1705	1707	ACC	192;194;196	A;C;C	170;174;174	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3912	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2243	172.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1759	1761	GCG	183;180;177	G;C;G	161;148;150	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3912	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2243	172.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1759	1761	GCG	183;180;177	G;C;G	161;148;150	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3912	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2243	172.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1882	1884	GGC	182;180;179	G;G;C	166;163;161	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3912	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2243	172.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1891	1893	GGC	179;177;175	G;G;C	161;157;156	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3912	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2243	172.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1909	1911	CTG	174;176;174	C,G;T,C;G	137,6;136,1;132	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5908	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3049	193.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1621	1623	CCG	200;198;201	C;C;G,A	176;185;181,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1958	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1691	115.1	0	.	p	.	0	S22G	NONSYN	64	66	AGC	257	259	GGC	106;105;107	G;G;C	100;101;103	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1958	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1691	115.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	439	439	C	124	C	110	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	484	486	CAG	248;250;251	C;A,G;G,T	228;232,1;230,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	E48G	NONSYN	142	144	GAA	508	510	GGA	279;279;280	G,T;G;A,G	257,1;258;260,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	V75I	NONSYN	223	225	GTT	589	591	ATT	258;254;258	A,G;T;T	234,1;232;236	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	631	633	AGC	226;222;224	A;G,C;C	211;205,1;204	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	V98I	NONSYN	292	294	GTC	658	660	ATC	211;208;204	A,C;T;C	194,1;189;191	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	723	724	CG	190;191	C;G,A	178;170,2	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	726	728	CAG	190;189;190	C,G;A,C;G,A	173,2;176,1;174,2	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	730	732	AAA	193;193;191	A,C;A;A,C	180,1;182;178,2	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	F131H	NONSYN	391	393	TTT	757	759	CAT	191;188;188	C,T;A,T;T	183,1;178,1;178	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	N134E	NONSYN	400	402	AAT	766	768	GAG	182;183;183	G;A;G,T	174;174;175,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	V135L	NONSYN	403	405	GTG	769	771	CTT	183;186;187	C,G;T;T,G	174,1;174;177,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	G140K	NONSYN	418	420	GGA	784	786	AAA	188;189;194	A,G;A,G;A	177,1;178,2;185	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	A142V	NONSYN	424	426	GCC	790	792	GTC	198;197;194	G;T,C;C	188;175,1;181	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	793	795	GAA	187;190;193	G,C;A;A	175,1;177;181	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	817	819	GCA	199;201;201	G,A;C,T;A	188,1;191,1;190	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	1000	1000	T	232	T	217	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	1	SNP	p	G120K	1	.	.	358	360	AAG	723	725	CGG	190;191;191	C;G,A;G,A	178;170,2;176,2	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	1	SNP	p	A121D	1	.	.	361	363	GAC	726	729	CGC	190;190;193	C,G;G,A;C	173,2;174,2;181	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2888	porB1b	1041	1041	95.54	porB1b.l15.c30.ctg.1	1559	184.6	1	SNP	p	D121N	0	.	.	361	363	GAC	726	729	CGC	190;190;193	C,G;G,A;C	173,2;174,2;181	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11756	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4864	240.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1240	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1117	110.4	1	SNP	p	V57M	1	.	.	169	171	ATG	529	531	ATG	264;267;268	A;T;G	247;249;249	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	M177T	NONSYN	529	531	ATG	890	892	ACG	575;565;558	A;C,T;G,A	547;540,1;532,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	911	913	GAC	482;477;473	G,C;A;C	475,1;471;468	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	T190M	NONSYN	568	570	ACG	929	931	ATG	458;459;459	A;T;G	456;456;456	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	L194S	NONSYN	580	582	TTA	941	943	TCA	443;435;438	T,A;C,A;A	440,1;431,1;437	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	986	988	CAG	418;422;422	C;A;G,C	414;419;418,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1007	1009	CTT	433;426;427	C;T;T	431;425;426	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1028	1030	AGT	459;466;468	A;G,A;T	443;446,2;442	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1097	1099	CCG	701;705;707	C;C;G	655;659;656	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1199	1201	TCG	734;731;729	T;C;G	697;690;684	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1370	1372	AAA	376;366;359	A;A;A	356;347;342	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1373	1375	AAG	354;352;352	A;A;G,T	337;334;333,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1388	1390	CAC	303;302;298	C;A;C	298;291;297	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1427	1429	GAA	290;292;296	G;A;A	288;291;296	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1505	1507	ACG	218;216;213	A;C;G,T	215;215;211,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1556	1558	ATT	317;315;318	A,C;T;T	296,1;297;299	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1559	1561	AGT	315;315;315	A;G;T	297;297;295	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1598	1600	CTA	360;361;371	C;T;A	324;328;335	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1640	1642	AAT	247;254;253	A;A;T	241;249;246	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1709	1711	TCA	351;353;358	T;C;A	330;330;330	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1733	1735	ATG	366;367;370	A;T;G	352;355;353	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2027	2029	ACC	795;795;794	A,C;C,T,G;C,A	739,1;742,1,1;737,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	13622	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2506	540.4	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2123	2125	GAA	747;741;746	G;A;A	703;698;705	.	Tetracycline resistance
